Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
110 participants
OBSERVATIONAL
2016-02-29
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
NCT02943304
Zika Virus Infection's Pregnancy Consequences in French Department of America
NCT02916732
ZIKAlliance Pregnant Women Cohort
NCT03188731
Prospective Study on the Risks of Dengue Fever for the Fetus.
NCT04822441
Study on the Risks of Symptomatic Dengue on Pregnancy
NCT04826081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cases
Mothers who delivered a baby with microcephaly at Nossa Senhora de Lourdes maternity hospital located in Aracaju, state of Sergipe, Brazil from September 1, 2015 through January 5, 2016. The intervention will be a questionary.
Questionary
Questionary with clinical, demographic and behavior outcomes at the pregnancy period
Controls
Mothers who delivered a baby without microcephaly at Nossa Senhora de Lourdes maternity hospital located in Aracaju, state of Sergipe, Brazil from September 1, 2015 through January 5, 2016. The intervention will be a questionary.
Questionary
Questionary with clinical, demographic and behavior outcomes at the pregnancy period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionary
Questionary with clinical, demographic and behavior outcomes at the pregnancy period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratório Sabin
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gustavo Barcelos Barra
Pharm.D Ph.D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gustavo B Barra, ph.D
Role: PRINCIPAL_INVESTIGATOR
Sabin Laboratory
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sabin laboratory
BrasÃlia, Federal District, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Santa Rita TH, Barra RB, Peixoto GP, Mesquita PG, Barra GB. Association between suspected Zika virus disease during pregnancy and giving birth to a newborn with congenital microcephaly: a matched case-control study. BMC Res Notes. 2017 Sep 6;10(1):457. doi: 10.1186/s13104-017-2796-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Zika and microcephaly
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.